Which drug is commonly used as a pre-treatment during RSI to blunt sympathetic response and reduce risk during intubation?

• A. Fentanyl
• B. Lidocaine
• C. Propofol
• D. Etomidate

Answer: (A)

Blunting the hemodynamic surge from airway manipulation is the main idea here. During rapid sequence intubation, laryngoscopy can provoke a sharp sympathetic response—tachycardia and hypertension—that increases myocardial oxygen demand and can be risky in patients with cardiovascular disease or intracranial pathology. An opioid given before induction, specifically fentanyl, dampens that sympathetic discharge, reducing the risk of significant blood pressure and heart rate spikes without greatly delaying induction. Its rapid onset and short duration fit well with the RSI workflow when used cautiously, typically at a modest dose to avoid excessive respiratory depression.

Lidocaine can help reduce coughing and some reflexes at the moment of intubation, and may lower spikes in intracranial pressure, but it does not reliably blunt the systemic sympathetic response as effectively as fentanyl. Propofol and etomidate are induction agents chosen for their hemodynamic effects rather than as pre-treatment to blunt sympathetic surge; propofol can cause hypotension, while etomidate maintains stability but doesn’t address the sympathetic reflex to laryngoscopy.

So, for pre-treatment during RSI aimed at blunting the sympathetic response and reducing intubation risk, fentanyl is the best choice.